Latent class analysis identifies three biologically distinct phenotypes among patients undergoing endovascular thrombectomy: a derivation and temporal validation study
Related Experiment Videos
Li-Li Yang1, Chao Chen1, Li-Li Sun1
1Department of Neurology, Taizhou Hospital of Zhejiang Province, Affiliated to Wenzhou Medical University, Linhai, Zhejiang, China.
Background:
Despite successful vascular recanalization, approximately half of patients undergoing endovascular thrombectomy (EVT) fail to achieve functional independence at 3 months. The biological determinants of this heterogeneity remain poorly characterized.
Methods:
Latent class analysis (LCA) was applied to 825 consecutive EVT-treated patients (development cohort, January 2021-December 2024) using 12 routine post-procedural clinical and laboratory indicators. Phenotype associations with favorable 3-month outcome (modified Rankin Scale 0-2) were assessed using multivariable logistic regression. Reproducibility was evaluated in an independent temporal validation cohort (n = 211).
Results:
LCA identified three phenotypes. The Low-burden phenotype (Class 1, 44.4%) had the lowest inflammatory and coagulatory burden and achieved favorable outcome in 70.8% of patients. The Metabolic phenotype (Class 2, 42.7%), characterized by hyperglycemia and elevated neutrophil-to-lymphocyte ratio, had a favorable outcome rate of 44.9% and symptomatic intracranial hemorrhage (sICH) rate of 7.1%. The hypercoagulable phenotype (Class 3, 13.0%), defined by markedly elevated D-dimer and atrial fibrillation, had a favorable outcome rate of 40.2% and sICH rate of 8.4%. After multivariable adjustment, both Class 2 (OR 0.49, 95% CI 0.35-0.69) and Class 3 (OR 0.41, 95% CI 0.25-0.67) were independently associated with unfavorable outcome (both p < 0.001). Class distribution and outcome associations were reproduced in the validation cohort.
Conclusion:
LCA identified three biologically distinct phenotypes among EVT-treated patients with divergent functional outcomes. Multicenter prospective validation is needed before these findings can inform clinical practice.